OpenClinica Announces 2013 Global Conference
The 2013 OpenClinica Global Conference will take place June 21-22, 2013 at the Sheraton Hotel in Boston, Massachusetts. This event is open to all who are looking to obtain insight, learn useful new skills, and build relationships within the growing OpenClinica
The conference is currently accepting early bird registrants, as well as proposals for speaking sessions and technology demonstrations. Submission guidelines may be found on the conference website.
“The OpenClinica community consists of users and developers distributed throughout the world, so this is a unique opportunity for high quality face-to-face interaction,” said Ben Baumann, Chair of the OpenClinica Conference Committee. “Attendees should find this year’s event to be the biggest and best yet.”
The 2013 conference includes formal, multi-day classroom training, as well as a series of ½ - 1 day long hands-on
Kicking-off the conference as keynote speaker is Douglas Bain, a recognized veteran in the eclinical industry who has worked in a leadership role with many prominent clinical research technology leaders including IBM and Medidata. In his address, Mr. Bain will focus on the emerging dynamics of patient centered clinical trials.
“I am thrilled to deliver the keynote at this year’s OpenClinica conference,” said Mr. Bain. “Clinical research modalities are changing, and I look forward to sharing my insights into where things are headed with such an innovative community.”
Conference attendees are invited aboard
Also in Boston, immediately following the OpenClinica Global Conference, is the 49th
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025